Citadel Advisors Llc (Ken Griffin) - Significant Ownership

Notable people
Ken Griffin
Signature - Title
/s/ Seth Levy - Seth Levy, Authorized Signatory
Location
Miami, FL
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Citadel Advisors Llc.

Significant Ownership of Citadel Advisors Llc

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ASST Strive, Inc. Class A Common Stock, $0.001 par value per share (the "Shares") 9.99% $104M 41.4M Kenneth Griffin Sep 30, 2025
AREC American Resources Corporation Class A common stock, par value $0.0001 per share (the "Shares") 9.99% $26.6M 9.87M Kenneth Griffin Oct 14, 2025
SPRB Spruce Biosciences, Inc. Common Stock, par value $0.0001 per share (the "Shares") 9.99% $1.36M 110K Citadel Advisors LLC Oct 9, 2025
MEIP MEI Pharma, Inc. Common Stock, par value $0.00000002 per share (the "Shares") 9.99% 3.25M Kenneth Griffin Jul 22, 2025
FLYY Spirit Aviation Holdings, Inc. Common Stock, par value $0.0001 per share (the "Shares") 9.9% $14.5M 1.62M Kenneth Griffin Apr 29, 2025
LXEO Lexeo Therapeutics, Inc. Common Stock ($0.0001 par value) (the "Shares") 9.6% $24.5M 5.33M Kenneth Griffin Jun 30, 2025
NB NioCorp Developments Ltd. Common Shares, without par value (the "Shares") 8.2% $53.1M $27M 7.95M +104% Kenneth Griffin Sep 30, 2025
ASST ASSET ENTITIES INC. Class B Common Stock, par value $0.0001 per share (the "Shares") 8.1% $4.29M 1.27M Kenneth Griffin Aug 18, 2025
SPAI Safe Pro Group Inc. Common Stock, par value $0.0001 per share (the "Shares") 6.7% $9.21M -$1.34M 1.31M -12.7% Kenneth Griffin Sep 30, 2025
FGNX FG Nexus Inc. Common Stock, par value $0.001 per share (the "Shares") 6.6% $61.4M 2.5M Kenneth Griffin Sep 5, 2025
DBVT DBV Technologies S.A. Ordinary shares, nominal value EUR0.10 per share (the "Shares") 6.4% $78.4M 9.19M Kenneth Griffin Apr 7, 2025
BOLD Boundless Bio, Inc. Common stock, par value $0.0001 per share (the "Shares") 6.4% $1.76M 1.43M Kenneth Griffin Nov 26, 2025
NA Nano Labs Ltd Class A ordinary shares, par value US$0.002 per share (the "Shares") 6.2% $7.35M -$3.92M 1.36M -34.8% Kenneth Griffin Sep 30, 2025
SNCY Sun Country Airlines Holdings, Inc. Common Stock, par value $0.01 per share (the "Shares") 6.1% $30.1M 3.2M Kenneth Griffin Feb 11, 2025
ALLO Allogene Therapeutics, Inc. Common Stock, par value $0.001 per share (the "Shares") 6.1% $15.1M 13.3M Kenneth Griffin Jul 9, 2025
INSP Inspire Medical Systems, Inc. Common Stock, par value $0.001 per share (the "Shares") 5.8% $127M 1.71M Kenneth Griffin Sep 29, 2025
AARD Aardvark Therapeutics, Inc. Common Stock, par value $0.00001 per share (the "Shares") 5.6% $13.6M 1.19M Kenneth Griffin Feb 14, 2025
RZLV Rezolve AI plc Ordinary Shares, par value (GBP)0.0001 per share (the "Shares") 5.5% $106M 15.7M Kenneth Griffin Sep 25, 2025
ACRV Acrivon Therapeutics, Inc. Common Stock, par value $0.001 per share (the "Shares") 5.5% $3.12M $327K 1.72M +11.7% Kenneth Griffin Nov 14, 2025
HOND HCM II Acquisition Corp. Class A Ordinary Shares, par value $0.0001 per share (the "Shares") 5.4% $14.3M 1.23M Kenneth Griffin Sep 23, 2025
CRBP Corbus Pharmaceuticals Holdings, Inc. Common Stock, par value $0.0001 per share (the "Shares") 5.3% $12.4M 981K Kenneth Griffin Nov 4, 2025
QUBT Quantum Computing Inc. Common stock, par value $0.0001 per share (the "Shares") 4.9% $147M 9.24M Kenneth Griffin Sep 25, 2025
TARA Protara Therapeutics, Inc. Common Stock, $0.001 par value per share (the "Shares") 4.7% $7.03M 1.63M Kenneth Griffin Dec 31, 2024
DFDV DeFi Development Corp. Common Stock, par value $0.00001 per share (the "Shares") 4.5% $20M 1.32M Kenneth Griffin Oct 14, 2025
SLRN ACELYRIN, Inc. Common Stock, par value $0.00001 per share (the "Shares") 4.2% $10.3M 4.22M Kenneth Griffin Dec 31, 2024
TERN Terns Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (the "Shares") 4.1% $10.1M 3.47M Kenneth Griffin Dec 31, 2024
NKTX Nkarta, Inc. Common Stock, par value $0.0001 per share (the "Shares") 4.1% $6M 2.9M Kenneth Griffin Sep 30, 2025
SPHR Sphere Entertainment Co. Class A Common Stock 3.9% $29.5M 1.12M Kenneth Griffin Mar 31, 2025
KRRO Korro Bio, Inc. Common Stock, par value $0.001 per share (the "Shares") 3.9% $6.16M 370K Citadel Advisors LLC Dec 31, 2024
ALHC Alignment Healthcare, Inc. Common Stock, par value $0.001 per share (the "Shares") 3.4% $117M -$66.1M 6.72M -36.1% Kenneth Griffin Sep 30, 2025
CGEM Cullinan Therapeutics, Inc. Common Stock, par value $0.0001 per share (the "Shares") 3.4% $11.8M -$6.05M 1.99M -33.9% Kenneth Griffin Sep 30, 2025
CABA Cabaletta Bio, Inc. Common stock, par value $0.00001 per share (the "Shares") 3.4% $7.37M -$3.9M 3.15M -34.6% Kenneth Griffin Sep 30, 2025
DGXX DIGI POWER X INC. Subordinate Voting Shares, with no par value per share (the "Shares") 3.4% $3.47M 1.52M Kenneth Griffin Oct 10, 2025
BBOT BridgeBio Oncology Therapeutics, Inc. Class A ordinary share, par value $0.0001 per share (the "Shares") 3.2% $29.4M 2.54M Kenneth Griffin Sep 30, 2025
UWMC UWM Holdings Corporation Class A Common Stock, par value $0.0001 per share (the "Shares") 2.8% $23.8M -$32.6M 5.58M -57.8% Kenneth Griffin Jun 30, 2025
BKKT Bakkt Holdings, Inc. Class A Common Stock, par value $0.0001 per share (the "Shares") 2.7% $14.3M -$30.1M 426K -67.7% Kenneth Griffin Sep 30, 2025
FVR FrontView REIT, Inc. Common Stock, $0.01 par value 2.4% $4.92M 409K Kenneth Griffin Mar 31, 2025
ADT ADT Inc. Common stock, par value $0.01 per share (the "Shares") 2.2% $147M -$222M 17.5M -60.2% Kenneth Griffin Jun 30, 2025
VTYX Ventyx Biosciences, Inc. Common Stock, par value $0.0001 per share 2% $1.78M 1.41M Kenneth Griffin Mar 31, 2025
CMPS COMPASS Pathways plc Ordinary Shares, par value of GBP 0.008 per share (the "Shares"), each represented by one American Depositary Share 1.7% $4.4M 1.17M Kenneth Griffin Dec 31, 2024
ARVN ARVINAS, INC. Common stock, par value $0.001 per share (the "Shares") 0.4% $2.25M -$27.4M 264K -92.4% Kenneth Griffin Sep 30, 2025
ALTS ALT5 Sigma Corporation Common Stock, par value $0.001 per share (the "Shares") 0.2% $1.76M 283K Kenneth Griffin Aug 12, 2025
VYNE VYNE Therapeutics Inc. Common Stock, par value $0.0001 (the "Shares") 0% $1.25K -$367K 3.73K -99.7% Kenneth Griffin Sep 30, 2025
CBNA Chain Bridge Bancorp, Inc. Class A common stock, par value $0.01 per share 0% $0 0 Citadel Advisors LLC Mar 31, 2025
HE HAWAIIAN ELECTRIC INDUSTRIES INC Common Stock, Without Par Value (the "Shares") 0% $0 0 Citadel Advisors LLC Dec 31, 2024
LYRA Lyra Therapeutics, Inc. Common Stock, $0.001 par value per share (the "Shares") 0% $0 0 Citadel Advisors LLC Dec 31, 2024

Schedules 13D/G Reported by Citadel Advisors Llc:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.